Vaccinex Inc. (VCNX) upgraded Issued by Wall Street Gurus

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Vaccinex Inc. (NASDAQ:VCNX) went down by -7.67% from its latest closing price compared to the recent 1-year high of $9.56. The company’s stock price has collected -12.53% of loss in the last five trading sessions. Press Release reported on 02/22/21 that Vaccinex Announces Licensing of Anti-CCR8 Antibody to Surface Oncology

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Is It Worth Investing in Vaccinex Inc. (NASDAQ :VCNX) Right Now?

Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Vaccinex Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.


The average price from analysts is $7.00. VCNX currently public float of 18.27M and currently shorts hold a 3.43% ratio of that float. Today, the average trading volume of VCNX was 5.62M shares.

VCNX’s Market Performance

VCNX stocks went down by -12.53% for the week, with a monthly jump of 47.88% and a quarterly performance of 66.19%, while its annual performance rate touched -33.90%. The volatility ratio for the week stands at 12.05% while the volatility levels for the past 30 days are set at 17.03% for Vaccinex Inc.. The simple moving average for the period of the last 20 days is 0.91% for VCNX stocks with a simple moving average of 0.36% for the last 200 days.

Analysts’ Opinion of VCNX

Ladenburg Thalmann, on the other hand, stated in their research note that they expect to see VCNX reach a price target of $22. The rating they have provided for VCNX stocks is “Buy” according to the report published on September 04th, 2018.

VCNX Trading at 26.02% from the 50-Day Moving Average

After a stumble in the market that brought VCNX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -63.49% of loss for the given period.

Volatility was left at 17.03%, however, over the last 30 days, the volatility rate increased by 12.05%, as shares surge +39.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +72.77% upper at present.

During the last 5 trading sessions, VCNX fell by -12.53%, which changed the moving average for the period of 200-days by -11.65% in comparison to the 20-day moving average, which settled at $3.51. In addition, Vaccinex Inc. saw 68.60% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at VCNX starting from FRIEDBERG ALBERT, who purchase 1,126,760 shares at the price of $3.55 back on Jul 10. After this action, FRIEDBERG ALBERT now owns 1,710,093 shares of Vaccinex Inc., valued at $3,999,998 using the latest closing price.

Stock Fundamentals for VCNX

Current profitability levels for the company are sitting at:

  • -6121.41 for the present operating margin
  • +14.34 for the gross margin

The net margin for Vaccinex Inc. stands at -6092.35. Equity return is now at value 113.00, with -367.10 for asset returns.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

The receivables turnover for the company is 0.68 and the total asset turnover is 0.04. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.58.

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Important Earnings

Insider Watchlist

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.